Phreesia’s Danielle Lynch Named One of MM+M’s ‘Women to Watch’ for 2022

Rhea-AI Summary

Phreesia has announced that Danielle Lynch, Vice President of Client Experience, is recognized among the 'Women to Watch' by MM+M. This accolade honors influential leaders in healthcare marketing, with Lynch being one of only 25 selected for 2022.

Since Phreesia's IPO in 2019, Lynch has doubled her team and contributed to a nearly 100% increase in Life Sciences revenue, showcasing her innovation and leadership. David Linetsky praised her for building the Client Experience team that drives Phreesia Life Sciences' growth.

Positive

• Danielle Lynch recognized as one of 25 'Women to Watch' by MM+M.
• Lynch doubled her team size and boosted Life Sciences revenue by nearly 100% since 2019.

Negative

• None.

RALEIGH, N.C.--(BUSINESS WIRE)-- Phreesia is pleased to announce that the healthcare marketing industry trade MM+M has named Danielle Lynch, Vice President, Client Experience, to its Women to Watch class of 2022.

Now in its seventh year, the program recognizes successful leaders and up-and-coming talent in the industry who have inspired their colleagues, showcased new ways of doing business and taken healthcare marketing to new heights. Lynch was chosen as one of just 25 women to receive this year’s honors.

“I’m honored to be recognized by MM+M alongside such esteemed women leaders in the healthcare marketing field,” Lynch said. “I’m incredibly proud of the Phreesia Life Sciences team and the success we’ve achieved through hard work and collaboration.”

Since playing a pivotal role in taking Phreesia public in 2019, Lynch has doubled the size of her team and helped increase Life Sciences revenue by nearly 100%. She is admired by her colleagues for her innovation, tenacity, and her continued contributions to Phreesia's mission of creating a better, more engaging healthcare experience.

“We are thrilled to see Danielle awarded this well-deserved honor,” David Linetsky, Phreesia’s Senior Vice President, Life Sciences, said. “Danielle built the Client Experience team—the engine behind Phreesia Life Sciences’ significant growth—from the ground up, and her vision and leadership have been instrumental to the team’s success.”

About Phreesia Life Sciences

Phreesia empowers life sciences companies to connect meaningfully with clinically relevant patients, delivering targeted health content in a one-to-one setting. Our PatientConnect offering identifies and motivates the right patients to initiate meaningful brand conversations, and our PatientInsights product enables our clients to better understand their target patient populations.

Phreesia meets patients where they are, both virtually and in-person, and reaches them at multiple touchpoints throughout their healthcare journey. To learn more about Phreesia Life Sciences, visit lifesciences.phreesia.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220331005973/en/

Media Contact:

Carly Helfand

chelfand@phreesia.com

332-910-6768

Source: Phreesia

FAQ

What recognition did Phreesia receive in 2022?

Danielle Lynch was named among the 'Women to Watch' by MM+M.

Who is Danielle Lynch and what role does she play at Phreesia?

Danielle Lynch is the Vice President of Client Experience at Phreesia.

What impact has Danielle Lynch had on Phreesia's growth?

Under her leadership, Life Sciences revenue at Phreesia has increased by nearly 100%.

When did Phreesia go public?

Phreesia went public in 2019.

How has Danielle Lynch contributed to the Client Experience team?

Lynch built the Client Experience team from the ground up, driving significant growth for Phreesia Life Sciences.